1,10-phenanthroline has been researched along with 1,2-cyclohexanediamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldrich-Wright, JR; Clegg, JK; Deo, KM; Gilbert, J; Li, F; Macias, FJ; Pages, BJ; Sakoff, J; Wormell, P; Zhang, Y; Zheng, G | 1 |
| Aldrich-Wright, JR; Friedman-Ezra, A; Gibson, D; Harper, BW; Petruzzella, E; Sirota, R | 1 |
2 other study(ies) available for 1,10-phenanthroline and 1,2-cyclohexanediamine
| Article | Year |
|---|---|
Synthesis and Analysis of the Structure, Diffusion and Cytotoxicity of Heterocyclic Platinum(IV) Complexes.
Topics: Antineoplastic Agents; Cell Line; Crystallography, X-Ray; Cyclohexylamines; Ligands; Magnetic Resonance Spectroscopy; Molecular Structure; Organoplatinum Compounds; Phenanthrolines; Platinum; Stereoisomerism; Structure-Activity Relationship; X-Ray Diffraction | 2015 |
Probing the Interactions of Cytotoxic [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)] and Its Pt
Topics: Ascorbic Acid; Coordination Complexes; Cyclohexylamines; Drug Stability; Electrochemical Techniques; Humans; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Phenanthrolines; Platinum; Prohibitins | 2017 |